Northern Trust’s Anebulo Pharmaceuticals ANEB Stock Holding History

Northern Trust’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,994	Closed	-$22.2K	–	4402
2025 Q4	$22.2K	Sell	21,994 -2,399	-10%	-$5.47K	﹤0.01%	4385
2025 Q3	$61K	Buy	+24,393	New	+$57.4K	﹤0.01%	4244

Northern Trust's ANEB Position: Q1 2026 in Review

Northern Trust sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 21,994 shares — an estimated $22.2K sold.

Northern Trust first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $61K in Q3 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

Northern Trust reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Northern Trust sold 21,994 Anebulo Pharmaceuticals shares in Q1 2026, an estimated $22.2K.
Northern Trust first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Northern Trust's Anebulo Pharmaceuticals position peaked at $61K in Q3 2025.
0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.